Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

JD.com Stock Tanked Nearly 20% Last Quarter, but One Fund Still Bought Up $6 Million in Sharesjd-com
JD.com is a technology-driven retailer known for its integrated logistics and broad product portfolio serving consumers across China.
Via The Motley Fool · February 12, 2026
Why McGraw Hill Stock Jumped Todayfool.com
The textbook supplier is integrating artificial intelligence (AI) across its business.
Via The Motley Fool · February 12, 2026
This Nuclear Stock Could Be a Big Winner as the U.S. Rushes to Secure Its Fuel Supplyfool.com
Centrus Energy was recently awarded a large government task order to expand its uranium enrichment capabilities.
Via The Motley Fool · February 12, 2026
Coinbase (NASDAQ:COIN) Misses Q4 CY2025 Sales Expectations
Blockchain infrastructure company Coinbase (NASDAQ:COIN) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 21.6% year on year to $1.78 billion. Its non-GAAP profit of $0.66 per share was 31.2% below analysts’ consensus estimates.
Via StockStory · February 12, 2026
Dutch Bros (NYSE:BROS) Reports Upbeat Q4 CY2025, Stock Jumps 15.2%
Coffee chain Dutch Bros (NYSE:BROS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 29.4% year on year to $443.6 million. On the other hand, the company’s full-year revenue guidance of $2.02 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $0.17 per share was 73.9% above analysts’ consensus estimates.
Via StockStory · February 12, 2026
Trupanion (NASDAQ:TRUP) Posts Q4 CY2025 Sales In Line With Estimates
Pet insurance provider Trupanion (NASDAQ:TRUP) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.7% year on year to $376.9 million. Its GAAP profit of $0.13 per share was 19.6% below analysts’ consensus estimates.
Via StockStory · February 12, 2026
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $3.19 billion. The company expects the full year’s revenue to be around $13.03 billion, close to analysts’ estimates. Its non-GAAP profit of $5.03 per share was 2.3% below analysts’ consensus estimates.
Via StockStory · February 12, 2026
DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations
Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q4 CY2025, with sales up 13.1% year on year to $1.26 billion. The company expects the full year’s revenue to be around $5.21 billion, close to analysts’ estimates. Its non-GAAP profit of $0.68 per share was 4.5% above analysts’ consensus estimates.
Via StockStory · February 12, 2026
Applied Materials’s (NASDAQ:AMAT) Q4 Sales Top Estimates, Stock Soars
Semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 2.1% year on year to $7.01 billion. On top of that, next quarter’s revenue guidance ($7.65 billion at the midpoint) was surprisingly good and 8.1% above what analysts were expecting. Its non-GAAP profit of $2.38 per share was 7.8% above analysts’ consensus estimates.
Via StockStory · February 12, 2026
Why Is Nuclear Energy Stock Centrus Bleeding Red?fool.com
Centrus Energy stock cracks on weak numbers. Here's what investors should do.
Via The Motley Fool · February 12, 2026
Is Micron Technology Stock the Next Nvidia?fool.com
Shares in this computer memory specialist have soared over the last few months. But what comes next?
Via The Motley Fool · February 12, 2026
Why Is Fastly (FSLY) Stock Rocketing Higher Today
Shares of edge cloud platform Fastly (NYSE:FSLY) jumped 79.9% in the afternoon session after it reported strong fourth-quarter earnings that beat analyst sales and earnings estimates. Management attributed this performance to robust demand in its Network Services and Security segments, with security revenue growth accelerating and new products gaining traction with enterprise clients. CEO Kip Compton emphasized the company's ongoing focus on cross-sell opportunities and disciplined execution, citing larger customers directing more traffic to Fastly's platform due to stability and performance benefits. Looking ahead, guidance for sales and earnings also came in ahead of consensus. Overall, it was an impressive quarter.
Via StockStory · February 12, 2026
Why Zebra Technologies Stock Galloped 20% Higher Thursday Morningfool.com
Zebra Technologies isn't a flashy AI stock, but it might be a bargain-priced way to play the trend. Thursday's earnings report explained why.
Via The Motley Fool · February 12, 2026
Where Will Rivian Stock Be in 5 Years?fool.com
The company's future rides on new model releases.
Via The Motley Fool · February 12, 2026
1 Brilliant AI Stock That You Should Buy Hand Over Fist in 2026fool.com
Broadcom has plenty of upside potential.
Via The Motley Fool · February 12, 2026
ABCB Q4 Deep Dive: Organic Growth and Deposit Trends Shape Outlook for 2026
Regional banking company Ameris Bancorp (NYSE:ABCB) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.4% year on year to $309.9 million. Its non-GAAP profit of $1.59 per share was 0.9% above analysts’ consensus estimates.
Via StockStory · February 12, 2026
5 Insightful Analyst Questions From Ameris Bancorp’s Q4 Earnings Call
Ameris Bancorp’s fourth quarter results met Wall Street’s revenue expectations, supported by higher net interest income and disciplined expense management. Leadership cited steady loan growth, improved operating efficiency, and stable asset quality as primary drivers. CEO Palmer Proctor highlighted, “We reported record earnings for 2025 at over $412 million for the year with our diluted EPS hitting $6 per share for the first time in our history.” Management also pointed to robust loan pipelines, a growing core deposit base, and favorable Southeast market conditions as factors underpinning consistent profitability.
Via StockStory · February 12, 2026
TeraWulf Stock has Surged Over 200%, and One Fund Just Sold Off $12 Million in Sharesfool.com
TeraWulf operates large-scale bitcoin mining facilities in New York and Pennsylvania, using proprietary infrastructure and energy resources.
Via The Motley Fool · February 12, 2026
More Older Americans Are Un-Retiring. Should You?fool.com
There can be benefits to returning to work, but beware certain gotchas.
Via The Motley Fool · February 12, 2026
CoreCivic (CXW) Q4 2025 Earnings Call Transcriptfool.com
CoreCivic (CXW) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 12, 2026
Why Robinhood's Nearly 50% Slide Is a Buy-the-Dip Opportunitymarketbeat.com
Via MarketBeat · February 12, 2026
CXW Q4 Deep Dive: Federal Contract Wins and Facility Activations Drive Outlook Amid Market Skepticism
Private prison operator CoreCivic (NYSE:CXW) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 26% year on year to $604 million. Its GAAP profit of $0.26 per share was 30.9% above analysts’ consensus estimates.
Via StockStory · February 12, 2026
GEO Stock Down 40%, and One Major Investor Just Cut $6.7 Million From Its Stakefool.com
This security services provider delivers facility management, electronic monitoring, and reentry solutions to government agencies worldwide.
Via The Motley Fool · February 12, 2026
Trump Administration Still Running Budget Deficits Despite Surge In Tariff Revenuetalkmarkets.com
The federal government ran a $94.62 billion deficit in January, according to the monthly Treasury statement. That was down 26 percent compared to January 2025.
Via Talk Markets · February 12, 2026
Is Micron Stock Your Ticket to Becoming a Millionaire?fool.com
Micron works with the AI chipmakers and is directly positioned to benefit from any increases in AI spending.
Via The Motley Fool · February 12, 2026